Recent News

• 03.23.2026 - Cabaletta Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
• 03.23.2026 - Cabaletta Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
• 02.24.2026 - Cabaletta Bio to Participate in the TD Cowen 46th Annual Health Care Conference
• 02.24.2026 - Cabaletta Bio to Participate in the TD Cowen 46th Annual Health Care Conference
• 02.05.2026 - Cabaletta Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
• 02.05.2026 - Cabaletta Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026

Recent Filings

• 03.02.2026 - 4 Statement of changes in beneficial ownership of securities
• 03.02.2026 - 4 Statement of changes in beneficial ownership of securities
• 03.02.2026 - 4 Statement of changes in beneficial ownership of securities
• 03.02.2026 - 4 Statement of changes in beneficial ownership of securities
• 03.02.2026 - 4 Statement of changes in beneficial ownership of securities
• 03.02.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.18.2026 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 02.17.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 02.17.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 02.17.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors